These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 7671364)

  • 21. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The influence of 3-month treatment with molsidomine on structure, function and some neurohormonal parameters in patients with chronic heart failure treated with digoxin, diuretic and angiotensin converting enzyme inhibitors].
    Spring A; Jołda-Mydłowska B; Kosmala W; Witkowska M
    Pol Merkur Lekarski; 1998 Jun; 4(24):315-8. PubMed ID: 9771014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure.
    Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E
    Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure.
    van Veldhuisen DJ; Boomsma F; de Kam PJ; Man in't Veld AJ; Crijns HJ; Hampton JR; Lie KI
    Eur Heart J; 1998 May; 19(5):753-60. PubMed ID: 9717009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.
    Uretsky BF; Young JB; Shahidi FE; Yellen LG; Harrison MC; Jolly MK
    J Am Coll Cardiol; 1993 Oct; 22(4):955-62. PubMed ID: 8409069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Digoxin and angiotensin-converting enzyme inhibitors in the treatment of chronic congestive heart failure].
    Thery C
    Therapie; 1994; 49(3):211-8. PubMed ID: 7878586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical, echocardiographic, and neurohormonal effects of a sodium-restricted diet in dogs with heart failure.
    Rush JE; Freeman LM; Brown DJ; Brewer BP; Ross JN; Markwell PJ
    J Vet Intern Med; 2000; 14(5):513-20. PubMed ID: 11012115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
    Kromer EP; Elsner D; Riegger GA
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):9-14. PubMed ID: 1696671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
    Kinugawa T; Kato M; Mori M; Endo A; Kato T; Hamada T; Noguchi N; Omodani H; Osaki S; Ogino K; Miyakoda H; Hisatome I; Shigemasa C
    Eur J Clin Pharmacol; 1998 May; 54(3):209-14. PubMed ID: 9681661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
    Mitrovic V; Mudra H; Bonzel T; Schmidt W; Schlepper M
    Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment.
    Hou YP; Wu JL; Fan Q; Liu MB; Yin BL; Zhang L
    Clin Sci (Lond); 2007 Mar; 112(5):299-304. PubMed ID: 17020540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure.
    Brunner-La Rocca HP; Weilenmann D; Kiowski W; Maly FE; Candinas R; Follath F
    Am Heart J; 1999 Oct; 138(4 Pt 1):654-62. PubMed ID: 10502210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.
    Ahmed A; Rich MW; Fleg JL; Zile MR; Young JB; Kitzman DW; Love TE; Aronow WS; Adams KF; Gheorghiade M
    Circulation; 2006 Aug; 114(5):397-403. PubMed ID: 16864724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
    Park JW; Heinzler R; Wirtz JH; Fieten-Rumswinkel M; Braun P; May E; Hetzer R; Heinrich KW
    Z Kardiol; 1994; 83 Suppl 2():49-53. PubMed ID: 8091824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
    Lang RM; Elkayam U; Yellen LG; Krauss D; McKelvie RS; Vaughan DE; Ney DE; Makris L; Chang PI
    J Am Coll Cardiol; 1997 Oct; 30(4):983-91. PubMed ID: 9316528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme.
    Young JB; Gheorghiade M; Uretsky BF; Patterson JH; Adams KF
    J Am Coll Cardiol; 1998 Sep; 32(3):686-92. PubMed ID: 9741512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACE inhibitor co-therapy in patients with heart failure: rationale for the Randomized Aldactone Evaluation Study (RALES).
    Pitt D
    Eur Heart J; 1995 Dec; 16 Suppl N():107-10. PubMed ID: 8682055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group.
    Brouwer J; van Veldhuisen DJ; Man in 't Veld AJ; Dunselman PH; Boomsma F; Haaksma J; Lie KI
    J Am Coll Cardiol; 1995 Oct; 26(4):983-90. PubMed ID: 7560628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.